Bulk Pharmaceutical API Sources for ACUVAIL

Bulk Pharmaceutical API Sources for ACUVAIL

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		K1136_SIGMA
Molport		MolPort-003-666-507
Amadis Chemical		A838011
BioChemPartner		BCP0726000301

Bulk Active Pharmaceutical Ingredient (API) Sources for Acuvail

Last updated: July 28, 2025

Introduction

Acuvail, with the generic name ketorolac tromethamine ophthalmic solution (0.45%), is a non-steroidal anti-inflammatory drug (NSAID) used primarily in ophthalmology to manage postoperative inflammation and pain following ocular surgeries such as cataract extraction. As a sterile ophthalmic solution, the API sourcing process for Acuvail entails strict compliance with pharmaceutical quality standards, ensuring safety, efficacy, and regulatory adherence.

API Profile of Ketorolac Tromethamine

Ketorolac tromethamine is the active pharmaceutical ingredient responsible for the therapeutic effects of Acuvail. Its procurement from reliable bulk API suppliers is critical to maintain product integrity, stability, and regulatory approval.

Global API Manufacturing Landscape for Ketorolac Tromethamine

The global supply chain for ketorolac tromethamine API is concentrated among several prominent pharmaceutical API manufacturers spanning North America, Europe, and Asia. This concentrated landscape has implications for supply stability, compliance, and cost.

Major API Suppliers for Ketorolac Tromethamine

1. Covestro AG (formerly Bayer MaterialScience)

Covestro has historically supplied ketorolac tromethamine API through its diversified pharmaceutical manufacturing arm. Known for stringent quality standards, Covestro’s API offerings conform to current Good Manufacturing Practices (cGMP) and are certified by regulatory agencies such as the FDA and EMA. Their production facilities are ISO 9001 and ISO 13485 certified, ensuring high-quality API supply for ophthalmic applications.

2. Catalent Pharma Solutions

Catalent has expanded its portfolio to include high-quality APIs, including ketorolac tromethamine. They operate cGMP-compliant manufacturing sites and offer integrated supply chain solutions. Their APIs are validated for ophthalmic formulations, which is critical for Acuvail.

3. Piramal Pharma Solutions

Piramal is known for robust API development and manufacturing, offering ketorolac tromethamine API with comprehensive documentation and regulatory compliance. Their Indian manufacturing facilities are certified under major international standards (e.g., US FDA, EMA, WTO). Piramal’s strategic location provides cost-effective sourcing options with global outreach.

4. Hubei Hainuo Pharmaceutical Co., Ltd. (China)

Hubei Hainuo supplies bulk ketorolac tromethamine API, focusing on the Asian market. Their facilities adhere to cGMP standards, though regulatory recognition may vary based on destination markets. Their competitive pricing makes them a significant player for regional supply.

5. BJ Pharmaceutical Ltd. (India)

An emerging manufacturer specializing in NSAID APIs, BJ Pharmaceutical offers ketorolac tromethamine API conforming to international standards. Their capacity supports large-volume orders, catering to both domestic and international markets.

Regulatory Considerations & Qualification

Sourcing API for ophthalmic products like Acuvail entails rigorous qualification processes. Manufacturers must demonstrate cGMP compliance through regulatory audits, stability data, and batch consistency. The selection hinges on:

• Regulatory approvals in target markets.
• Supply chain stability and capacity.
• Proven track record for pharmaceutical-grade APIs.
• Cost-effectiveness balanced with quality.

Most suppliers are listed in major pharmacopoeias, notably the United States Pharmacopeia (USP) and European Pharmacopoeia (EP), ensuring their APIs meet recognized standards.

Supply Chain and Quality Assurance

Pharmaceutical companies procuring ketorolac tromethamine API for Acuvail prioritize suppliers with:

• Validity of DMFs (Drug Master Files).
• Batch-to-batch reproducibility.
• Complete analytical and stability data.
• Transparency regarding raw material sourcing and manufacturing processes.

All suppliers must undergo thorough qualification and validation procedures to ensure compliance with FDA or EMA standards, crucial for ophthalmic API applications.

Emerging Trends & Future Outlook

The API market for ketorolac tromethamine is influenced by global regulatory tightening, supply chain resilience, and strategic shifts toward regional manufacturing. The COVID-19 pandemic highlighted vulnerabilities in supply lines, prompting companies to diversify their sources and reinforce existing supplier relationships.

In response, some pharmaceutical manufacturers are investing in vertically integrated manufacturing, or establishing partnerships with emerging API producers in India and China, to ensure supply stability and cost management.

Key Challenges in API Sourcing for Acuvail

• Regulatory variability: Differing recognition of manufacturing standards across nations.
• Supply chain disruptions: Geopolitical and pandemic-related issues impacting lead times.
• Quality consistency: Ensuring reproducibility for sterile ophthalmic formulations.
• Cost considerations: Balancing high-quality specifications with economic sourcing.

Conclusion

Reliable bulk API sourcing for ketorolac tromethamine is vital for the consistent production of Acuvail. Leading global manufacturers such as Covestro, Catalent, Piramal, and emerging Asian suppliers represent key options, each with varying strengths in regulatory compliance, capacity, and cost. Strategic supplier qualification aligned with global regulatory standards ensures API quality, supply security, and compliance for ophthalmic pharmaceutical companies.

---

Key Takeaways

• The predominant API suppliers for ketorolac tromethamine include Covestro, Catalent, Piramal, and Asian manufacturers like Hubei Hainuo and BJ Pharmaceutical.
• Ensuring cGMP compliance and regulatory validation is critical for ophthalmic API procurement.
• Supply chain diversification is increasingly essential for mitigating disruption risks.
• Emerging manufacturers in Asia provide cost-effective alternatives with adequate regulatory validation.
• Maintaining high standards in API sourcing directly correlates with the safety, efficacy, and regulatory approval of Acuvail.

---

FAQs

Q1: What are the primary criteria when selecting an API supplier for Acuvail?
Answer: The selection hinges on cGMP compliance, regulatory approvals (FDA, EMA), supply stability, quality control measures, batch reproducibility, and cost-effectiveness.

Q2: Are Asian API manufacturers suitable for ophthalmic applications like Acuvail?
Answer: Yes, several Asian manufacturers, such as Hubei Hainuo and BJ Pharmaceutical, meet international quality standards, making them suitable for ophthalmic APIs, provided their manufacturing processes are validated and approved.

Q3: How does API quality impact Acuvail’s safety and efficacy?
Answer: High-quality APIs ensure the sterile, stable, and precise delivery of ketorolac tromethamine, directly influencing the safety, efficacy, and regulatory compliance of Acuvail.

Q4: What are the regulatory challenges associated with sourcing APIs globally?
Answer: Variability in regulatory recognition, differing quality standards, and potential supply chain disruptions pose challenges, necessitating rigorous qualification and validation processes.

Q5: How can pharmaceutical companies mitigate risks related to API supply disruptions?
Answer: Diversification of sourcing, strategic stockpiling, establishing agreements with multiple approved suppliers, and continuous supply chain audits are effective mitigation strategies.

---

References

1. U.S. Pharmacopeia. Ketorolac Tromethamine — USP Monograph.
2. European Pharmacopoeia. Ketorolac Tromethamine.
3. Global API Market Reports, 2022–2023.
4. Industry sources and pharmaceutical manufacturing registries.